Measurement of Anticoagulation in Patients on Dabigatran, Rivaroxaban, and Apixaban Therapy by Novel Automated Thrombelastography

Measurement of Anticoagulation in Patients on Dabigatran, Rivaroxaban, and Apixaban Therapy by Novel Automated Thrombelastography

Background Direct-acting oral anticoagulants (DOACs) do not require monitoring. Measurement of DOAC effect would be useful in the event of bleeding, trauma, and thromboembolism while on anticoagulation. We evaluated the effectiveness of the investigational DOAC assays on the TEG®6s Hemostasis Analyz...

Full description

Bibliographic Details
Main Authors: Ramin Artang, Joao D. Dias, Mark Walsh, Kevin Bliden, Jorn D. Nielsen, Maren Anderson, Brian C. Thurston, Udaya S. Tantry, Jan Hartmann, Paul A. Gurbel
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2021-10-01
Series:TH Open
Subjects:
clinical trials: oral anticoagulants
coagulation inhibitors
diagnosis management
apixaban
rivaroxaban
dabigatran
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/a-1692-1415

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/a-1692-1415

Similar Items